Pushpalatha Arakere, MD
Infectious Disease · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 32 years
- Graduated 1994
Offices
1 location
Hospitals listed: Adventist Health Hanford · Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arakere’s office at (559) 323-4987 to ask if they take your plan before you enroll.
California Medical Board record
Licence A88072 · Current
Licensed to practise in California · since 2004 · expires 2028-05-31 · Gulbarga University, Mahadevappa Rampure Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$199,999
Medicare paid this office $199,999 for 830 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 517 | $69,615 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 339 | $52,028 | $84 |
| Return visit (30+ min) | 200 | $32,952 | $91 |
| New patient visit (45+ min) | 139 | $15,936 | $115 |
| Critical care, first 30-74 minutes | 40 | $15,596 | $150 |
See all 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 517 | $69,615 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 339 | $52,028 | $84 |
| Return visit (30+ min) | 200 | $32,952 | $91 |
| New patient visit (45+ min) | 139 | $15,936 | $115 |
| Critical care, first 30-74 minutes | 40 | $15,596 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 85 | $8,986 | $56 |
| Short return visit (20+ min) | 40 | $2,916 | $57 |
Procedures Medicare counted
| Removal of tissue | 26 | More than 72% of doctors who do this |
Who their Medicare patients are
830 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 16% · Women 50% · Also on Medicaid 42% · Health risk score 2.80. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 58% · Chronic kidney disease 56% · Coronary heart disease 49% · Heart failure 44% · Depression 35% · Atrial fibrillation 32% · COPD 30% · Dementia 20% · Cancer 19% · Stroke 13%.
The office billed $374,295, Medicare allowed $259,278 and paid $199,999; for 2,043 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 830 | 2,043 | 74 | 2.80 | $374,295 | $199,999 |
| 2023 | 792 | 2,358 | 73 | 2.60 | $420,670 | $251,721 |
| 2022 | 791 | 1,979 | 73 | 2.59 | $359,860 | $215,496 |
| 2021 | 772 | 2,461 | 73 | 2.56 | $439,010 | $266,886 |
| 2020 | 779 | 2,968 | 73 | 2.82 | $518,570 | $311,060 |
| 2019 | 643 | 3,021 | 73 | 2.82 | $556,745 | $329,999 |
| 2018 | 654 | 2,521 | 72 | 3.04 | $436,380 | $273,057 |
| 2017 | 595 | 2,064 | 72 | 3.22 | $322,904 | $208,568 |
| 2016 | 494 | 2,807 | 72 | 2.86 | $292,970 | $191,301 |
| 2015 | 468 | 1,725 | 71 | 2.77 | $283,617 | $187,471 |
| 2014 | 451 | 2,026 | 72 | 2.78 | $337,015 | $222,588 |
| 2013 | 379 | 1,919 | 72 | 2.84 | $319,500 | $203,439 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 363 | $85,938 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 498 | $77,160 | $138 |
| Return visit (30+ min) | 158 | $26,773 | $101 |
| Critical care, first 30-74 minutes | 32 | $21,046 | $168 |
| Short return visit (20+ min) | 150 | $16,808 | $71 |
| New patient visit (45+ min) | 120 | $15,487 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,664 | $63 |
2022: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 504 | $86,377 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 305 | $48,592 | $82 |
| Critical care, first 30-74 minutes | 42 | $21,562 | $174 |
| Short return visit (20+ min) | 168 | $21,131 | $69 |
| Return visit (30+ min) | 117 | $16,118 | $95 |
| New patient visit (45+ min) | 88 | $11,694 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,792 | $57 |
| New patient visit (30+ min) | 33 | $2,745 | $83 |
2021: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 528 | $97,519 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 385 | $75,442 | $83 |
| Critical care, first 30-74 minutes | 38 | $29,558 | $178 |
| Short return visit (20+ min) | 158 | $20,985 | $72 |
| Return visit (30+ min) | 104 | $15,227 | $104 |
| New patient visit (45+ min) | 69 | $9,592 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $9,117 | $57 |
| New patient visit (30+ min) | 41 | $3,594 | $88 |
| Long return visit (40+ min) | 19 | $2,857 | $150 |
| Removal of tissue from wound, 20.0 sq cm or less | 16 | $2,320 | $83 |
2020: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 429 | $117,405 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 560 | $102,368 | $165 |
| Critical care, first 30-74 minutes | 36 | $32,770 | $181 |
| Return visit (30+ min) | 147 | $19,396 | $81 |
| New patient visit (45+ min) | 96 | $12,612 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $10,240 | $60 |
| Short return visit (20+ min) | 93 | $9,638 | $62 |
| Removal of tissue from wound, 20.0 sq cm or less | 23 | $3,289 | $78 |
| New patient visit (30+ min) | 13 | $1,169 | $90 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 326 | $126,891 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 418 | $81,557 | $162 |
| Critical care, first 30-74 minutes | 39 | $58,605 | $178 |
| Return visit (30+ min) | 191 | $41,382 | $87 |
| New patient visit (45+ min) | 112 | $14,986 | $134 |
| Removal of tissue from wound, 20.0 sq cm or less | 29 | $3,545 | $75 |
| Long return visit (40+ min) | 20 | $2,382 | $119 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 319 | $92,136 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 429 | $77,871 | $159 |
| Critical care, first 30-74 minutes | 50 | $50,598 | $173 |
| Return visit (30+ min) | 166 | $28,493 | $83 |
| New patient visit (45+ min) | 111 | $14,439 | $130 |
| Long return visit (40+ min) | 43 | $4,957 | $115 |
| Removal of tissue from wound, 20.0 sq cm or less | 31 | $3,575 | $67 |
2017: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 371 | $64,788 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 257 | $60,077 | $81 |
| Critical care, first 30-74 minutes | 45 | $33,665 | $173 |
| Return visit (30+ min) | 163 | $28,099 | $81 |
| New patient visit (45+ min) | 101 | $12,854 | $127 |
| Long return visit (40+ min) | 38 | $4,443 | $114 |
| Removal of tissue from wound, 20.0 sq cm or less | 21 | $2,773 | $60 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 187 | $47,158 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 259 | $46,730 | $159 |
| Critical care, first 30-74 minutes | 41 | $35,300 | $177 |
| Return visit (30+ min) | 179 | $33,323 | $85 |
| New patient visit (45+ min) | 168 | $21,850 | $130 |
| Removal of tissue from wound, 20.0 sq cm or less | 33 | $4,474 | $62 |
2015: 8 services
| Critical care, first 30-74 minutes | 47 | $44,860 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 173 | $40,291 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 217 | $39,594 | $162 |
| Return visit (30+ min) | 160 | $32,970 | $86 |
| New patient visit (45+ min) | 177 | $23,142 | $131 |
| Removal of tissue from wound, 20.0 sq cm or less | 39 | $3,918 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,206 | $110 |
| Injection of drug or substance under skin or into muscle | 11 | $316 | $18 |
2014: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 200 | $55,079 | $84 |
| Critical care, first 30-74 minutes | 58 | $53,369 | $179 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 233 | $41,875 | $163 |
| Return visit (30+ min) | 162 | $36,423 | $86 |
| New patient visit (45+ min) | 159 | $21,243 | $134 |
| Removal of tissue from wound, 20.0 sq cm or less | 47 | $7,034 | $64 |
| Extended inpatient or observation hospital service, first hour | 47 | $3,565 | $74 |
| Critical care, each additional 30 minutes | 12 | $1,076 | $90 |
| Injection of drug or substance under skin or into muscle | 11 | $272 | $21 |
2013: 10 services
| Critical care, first 30-74 minutes | 65 | $53,414 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 178 | $43,490 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 198 | $34,666 | $159 |
| Return visit (30+ min) | 133 | $28,867 | $86 |
| New patient visit (45+ min) | 121 | $16,124 | $133 |
| Removal of tissue from wound, 20.0 sq cm or less | 47 | $7,702 | $65 |
| Extended inpatient or observation hospital service, first hour | 102 | $7,587 | $72 |
| Critical care, each additional 30 minutes | 40 | $3,503 | $88 |
| Short return visit (20+ min) | 22 | $2,679 | $60 |
| Long return visit (40+ min) | 15 | $2,070 | $99 |
Medicaid work
$1,341 in 2024
Medicaid paid $1,341 for 485 billed services this clinician did in 2024, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 265 | $875 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 220 | $466 |
| 2024 | 485 | 2 | 44 | $1,341 |
| 2023 | 883 | 2 | 51 | $8,245 |
| 2022 | 504 | 2 | 34 | $4,890 |
| 2021 | 51 | 2 | 16 | $752 |
| 2020 | 136 | 2 | 19 | $3,327 |
| 2018 | 198 | 2 | 23 | $2,459 |
See the largest Medicaid services in earlier years
2023
| 1ST HOSP IP/OBS HIGH 75 | 391 | $4,431 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 492 | $3,814 |
2022
| 1ST HOSP IP/OBS HIGH 75 | 279 | $2,704 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 225 | $2,186 |
2021
| 1ST HOSP IP/OBS HIGH 75 | 28 | $505 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $247 |
2020
| 1ST HOSP IP/OBS HIGH 75 | 67 | $2,007 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 69 | $1,321 |
2018
| 1ST HOSP IP/OBS HIGH 75 | 170 | $2,129 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 28 | $330 |
Drugs they prescribed that Part D paid
$1,718,381
Pharmacies billed $1,718,381 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (19 of 2,091) in 2024. Above the middle of the specialty; the typical infectious disease clinician is at 0%.
1,788 generic and fewer than 11 brand-name prescriptions · $1,718,381 in drug cost · 1,074 antibiotic prescriptions to 281 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Arikayce | 23 | $350,114 | $15,222 |
| Nuzyra | 20 | $280,030 | $14,002 |
| Biktarvy | 48 | $200,958 | $4,187 |
| Symtuza | 34 | $155,228 | $4,566 |
| Cresemba | 19 | $123,368 | $6,493 |
See all 45 drugs
| Arikayce | 23 | $350,114 | $15,222 |
| Nuzyra | 20 | $280,030 | $14,002 |
| Biktarvy | 48 | $200,958 | $4,187 |
| Symtuza | 34 | $155,228 | $4,566 |
| Cresemba | 19 | $123,368 | $6,493 |
| Odefsey | 26 | $85,109 | $3,273 |
| Cabenuva | 13 | $80,629 | $6,202 |
| Tivicay | 12 | $61,443 | $5,120 |
| Genvoya | 13 | $45,773 | $3,521 |
| Prezcobix | 12 | $33,572 | $2,798 |
| Voriconazole | 36 | $30,843 | $857 |
| Fluconazole | 115 | $13,527 | $118 |
| Methenamine Hippurate | 131 | $9,346 | $71 |
| Doxycycline Hyclate | 208 | $8,512 | $41 |
| Ceftriaxone | 42 | $7,867 | $187 |
| Cefepime | 34 | $6,777 | $199 |
| Cefuroxime | 27 | $4,878 | $181 |
| Vancomycin | 35 | $4,386 | $125 |
| Amoxicillin-Clavulanate Potass | 96 | $4,221 | $44 |
| Piperacillin-Tazobactam | 14 | $3,627 | $259 |
| Itraconazole | 25 | $3,320 | $133 |
| Ethambutol | 89 | $3,135 | $35 |
| Estradiol | 38 | $3,072 | $81 |
| Cephalexin | 173 | $2,511 | $15 |
| Arnuity Ellipta | 12 | $2,463 | $205 |
| Rifampin | 77 | $2,309 | $30 |
| Dicloxacillin | 30 | $2,066 | $69 |
| Azithromycin | 109 | $2,023 | $19 |
| Wixela Inhub | 11 | $1,617 | $147 |
| Ampicillin Trihydrate | 33 | $1,518 | $46 |
| Linezolid | 15 | $1,307 | $87 |
| Celecoxib | 15 | $1,181 | $79 |
| Clindamycin | 32 | $1,151 | $36 |
| Cefazolin | 15 | $771 | $51 |
| Hydrocodone-Acetaminophen | 17 | $769 | $45 |
| Sulfamethoxazole-Trimethoprim | 48 | $552 | $12 |
| Valacyclovir | 19 | $532 | $28 |
| Penicillin V | 22 | $319 | $14 |
| Ciprofloxacin | 24 | $318 | $13 |
| Mirtazapine | 20 | $298 | $15 |
| Trazodone | 32 | $223 | $7 |
| Levofloxacin | 18 | $190 | $11 |
| Prednisone | 20 | $115 | $6 |
| Amoxicillin | 11 | $80 | $7 |
| Atorvastatin | 11 | $53 | $5 |
Year by year
| 2024 | 2,091 | 390 | 1% (19) | None | $1,718,381 |
| 2023 | 1,935 | 366 | 1% (24) | None | $1,814,962 |
| 2022 | 1,895 | 347 | 2% (40) | 16% | $1,471,225 |
| 2021 | 2,000 | 316 | 2% (35) | None | $1,786,647 |
| 2020 | 1,840 | 288 | 2% (42) | 19% | $1,699,524 |
| 2019 | 1,616 | 244 | 3% (41) | 23% | $1,545,819 |
| 2018 | 1,371 | 210 | 3% (36) | 20% | $864,129 |
| 2017 | 1,319 | 182 | 3% (38) | 26% | $708,098 |
| 2016 | 1,171 | 194 | 3% (35) | 20% | $651,666 |
| 2015 | 841 | 170 | 4% (30) | 11% | $291,401 |
| 2014 | 982 | 172 | 6% (59) | 16% | $355,936 |
| 2013 | 863 | 135 | 9% (80) | 21% | $260,212 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Arikayce | 38 | $571,294 | $15,034 |
| Symtuza | 55 | $282,937 | $5,144 |
| Biktarvy | 40 | $163,865 | $4,097 |
| Cresemba | 15 | $121,770 | $8,118 |
| Odefsey | 24 | $90,533 | $3,772 |
| Genvoya | 12 | $49,189 | $4,099 |
| Voriconazole | 23 | $18,094 | $787 |
| Doxycycline Hyclate | 165 | $14,830 | $90 |
| Methenamine Hippurate | 103 | $14,207 | $138 |
| Fluconazole | 95 | $13,200 | $139 |
| Ampicillin | 47 | $9,716 | $207 |
| Cefepime | 32 | $8,094 | $253 |
| Ceftriaxone | 29 | $7,731 | $267 |
| Vancomycin | 73 | $7,058 | $97 |
| Breo Ellipta | 12 | $4,748 | $396 |
| Azithromycin | 116 | $4,513 | $39 |
| Ethambutol | 97 | $4,432 | $46 |
| Amoxicillin-Clavulanate Potass | 75 | $4,174 | $56 |
| Estradiol | 47 | $3,967 | $84 |
| Cefuroxime | 20 | $3,785 | $189 |
| Cefazolin | 41 | $3,619 | $88 |
| Cephalexin | 121 | $3,458 | $29 |
| Arnuity Ellipta | 11 | $2,481 | $226 |
| Rifampin | 59 | $2,249 | $38 |
| Dicloxacillin | 22 | $1,848 | $84 |
| Nitrofurantoin Mono-Macro | 11 | $1,700 | $155 |
| Ampicillin-Sulbactam | 16 | $1,687 | $105 |
| Clindamycin | 52 | $1,556 | $30 |
| Hydrocodone-Acetaminophen | 20 | $1,313 | $66 |
| Valacyclovir | 18 | $1,085 | $60 |
| Sulfamethoxazole-Trimethoprim | 50 | $941 | $19 |
| Ampicillin Trihydrate | 16 | $932 | $58 |
| Penicillin V | 26 | $511 | $20 |
| Fluticasone Propionate | 13 | $412 | $32 |
| Rosuvastatin | 11 | $406 | $37 |
| Ciprofloxacin | 23 | $387 | $17 |
| Trazodone | 30 | $374 | $12 |
| Levofloxacin | 19 | $322 | $17 |
| Amoxicillin | 17 | $294 | $17 |
| Mirtazapine | 15 | $237 | $16 |
2022: 40 drugs
| Arikayce | 36 | $501,307 | $13,925 |
| Symtuza | 38 | $195,666 | $5,149 |
| Biktarvy | 45 | $178,852 | $3,974 |
| Odefsey | 25 | $86,685 | $3,467 |
| Genvoya | 12 | $46,452 | $3,871 |
| Voriconazole | 33 | $33,672 | $1,020 |
| Doxycycline Hyclate | 195 | $20,411 | $105 |
| Vancomycin | 26 | $17,307 | $666 |
| Methenamine Hippurate | 100 | $14,676 | $147 |
| Fluconazole | 103 | $14,039 | $136 |
| Efavirenz | 11 | $9,095 | $827 |
| Cefepime | 37 | $7,760 | $210 |
| Amoxicillin-Clavulanate Potass | 99 | $7,694 | $78 |
| Azithromycin | 94 | $5,756 | $61 |
| Piperacillin-Tazobactam | 13 | $5,168 | $398 |
| Ceftriaxone | 36 | $3,472 | $96 |
| Cephalexin | 133 | $3,351 | $25 |
| Rifampin | 55 | $3,196 | $58 |
| Clindamycin | 94 | $2,808 | $30 |
| Ethambutol | 59 | $2,793 | $47 |
| Nitrofurantoin Mono-Macro | 15 | $2,751 | $183 |
| Valacyclovir | 19 | $2,328 | $123 |
| Estradiol | 17 | $1,524 | $90 |
| Albuterol Sulfate Hfa | 18 | $1,311 | $73 |
| Hydrocodone-Acetaminophen | 19 | $1,215 | $64 |
| Ampicillin Trihydrate | 23 | $1,171 | $51 |
| Sulfamethoxazole-Trimethoprim | 44 | $567 | $13 |
| Penicillin V | 17 | $489 | $29 |
| Ciprofloxacin | 40 | $445 | $11 |
| Amoxicillin | 24 | $419 | $17 |
| Levofloxacin | 22 | $323 | $15 |
| Trazodone | 24 | $269 | $11 |
| Fluticasone Propionate | 14 | $201 | $14 |
| Pravastatin | 12 | $184 | $15 |
| Losartan | 12 | $184 | $15 |
| Terbinafine | 12 | $170 | $14 |
| Mirtazapine | 12 | $132 | $11 |
| Tramadol | 21 | $103 | $5 |
| Prednisone | 16 | $67 | $4 |
| Easy Touch Alcohol Prep Pads | 13 | $53 | $4 |
2021: 45 drugs
| Arikayce | 56 | $708,710 | $12,656 |
| Biktarvy | 46 | $169,924 | $3,694 |
| Symtuza | 27 | $139,798 | $5,178 |
| Cayston | 12 | $128,993 | $10,749 |
| Odefsey | 25 | $81,551 | $3,262 |
| Genvoya | 14 | $57,390 | $4,099 |
| Prezista | 12 | $23,481 | $1,957 |
| Isentress | 12 | $22,082 | $1,840 |
| Intelence | 13 | $19,360 | $1,489 |
| Emtricitabine-Tenofovir Disop | 11 | $18,380 | $1,671 |
| Doxycycline Hyclate | 165 | $16,711 | $101 |
| Ertapenem | 15 | $14,368 | $958 |
| Fluconazole | 94 | $14,027 | $149 |
| Voriconazole | 25 | $13,401 | $536 |
| Vancomycin | 101 | $12,702 | $126 |
| Methenamine Hippurate | 101 | $11,824 | $117 |
| Efavirenz | 11 | $6,270 | $570 |
| Amoxicillin-Clavulanate Potass | 95 | $5,266 | $55 |
| Azithromycin | 115 | $4,982 | $43 |
| Nitrofurantoin Mono-Macro | 23 | $4,153 | $181 |
| Ethambutol | 84 | $4,052 | $48 |
| Ceftriaxone | 46 | $3,469 | $75 |
| Cefepime | 30 | $2,918 | $97 |
| Rifampin | 76 | $2,880 | $38 |
| Dicloxacillin | 26 | $2,860 | $110 |
| Clindamycin | 84 | $2,599 | $31 |
| Valacyclovir | 17 | $2,511 | $148 |
| Cephalexin | 83 | $2,171 | $26 |
| Estradiol | 13 | $1,753 | $135 |
| Ampicillin Trihydrate | 27 | $1,509 | $56 |
| Albuterol Sulfate Hfa | 14 | $1,279 | $91 |
| Hydrocodone-Acetaminophen | 25 | $1,267 | $51 |
| Ritonavir | 12 | $1,246 | $104 |
| Doxycycline Monohydrate | 18 | $863 | $48 |
| Sulfamethoxazole-Trimethoprim | 36 | $595 | $17 |
| Fluticasone Propionate | 29 | $415 | $14 |
| Penicillin V | 14 | $333 | $24 |
| Trazodone | 28 | $293 | $10 |
| Levofloxacin | 21 | $280 | $13 |
| Ciprofloxacin | 22 | $247 | $11 |
| Mirtazapine | 15 | $238 | $16 |
| Amoxicillin | 15 | $229 | $15 |
| Pravastatin | 12 | $116 | $10 |
| Pantoprazole | 11 | $84 | $8 |
| Losartan | 12 | $36 | $3 |
2020: 42 drugs
| Arikayce | 62 | $743,361 | $11,990 |
| Biktarvy | 52 | $174,431 | $3,354 |
| Genvoya | 19 | $62,418 | $3,285 |
| Odefsey | 19 | $57,302 | $3,016 |
| Truvada | 13 | $25,253 | $1,943 |
| Fluconazole | 110 | $22,468 | $204 |
| Prezista | 12 | $21,625 | $1,802 |
| Isentress | 12 | $19,979 | $1,665 |
| Vancomycin | 64 | $18,646 | $291 |
| Intelence | 11 | $15,583 | $1,417 |
| Methenamine Hippurate | 124 | $13,423 | $108 |
| Voriconazole | 33 | $13,202 | $400 |
| Doxycycline Hyclate | 145 | $11,073 | $76 |
| Efavirenz | 11 | $8,537 | $776 |
| Ceftriaxone | 43 | $7,765 | $181 |
| Cefepime | 19 | $4,771 | $251 |
| Azithromycin | 84 | $4,522 | $54 |
| Ampicillin-Sulbactam | 20 | $4,267 | $213 |
| Ethambutol | 66 | $4,167 | $63 |
| Amoxicillin-Clavulanate Potass | 54 | $3,956 | $73 |
| Dicloxacillin | 30 | $3,745 | $125 |
| Nitrofurantoin Mono-Macro | 21 | $3,288 | $157 |
| Cephalexin | 83 | $1,787 | $22 |
| Ampicillin Trihydrate | 24 | $1,589 | $66 |
| Ampicillin | 15 | $1,551 | $103 |
| Ritonavir | 12 | $1,467 | $122 |
| Clindamycin | 55 | $1,458 | $27 |
| Cefazolin | 22 | $1,368 | $62 |
| Ventolin Hfa | 15 | $1,329 | $89 |
| Hydrocodone-Acetaminophen | 28 | $1,198 | $43 |
| Rifampin | 46 | $1,158 | $25 |
| Amoxicillin | 30 | $442 | $15 |
| Sulfamethoxazole-Trimethoprim | 49 | $422 | $9 |
| Fluticasone Propionate | 21 | $419 | $20 |
| Ciprofloxacin | 27 | $392 | $15 |
| Penicillin V | 15 | $237 | $16 |
| Trazodone | 24 | $176 | $7 |
| Pravastatin | 11 | $123 | $11 |
| Mirtazapine | 14 | $80 | $6 |
| Pantoprazole | 25 | $80 | $3 |
| Tramadol | 13 | $61 | $5 |
| Losartan | 11 | $37 | $3 |
2019: 46 drugs
| Arikayce | 62 | $684,704 | $11,044 |
| Biktarvy | 29 | $106,040 | $3,657 |
| Egrifta | 18 | $96,330 | $5,352 |
| Odefsey | 27 | $76,895 | $2,848 |
| Genvoya | 12 | $37,180 | $3,098 |
| Voriconazole | 38 | $31,455 | $828 |
| Prezista | 13 | $22,458 | $1,728 |
| Fluconazole | 126 | $20,911 | $166 |
| Vancomycin | 30 | $20,782 | $693 |
| Isentress | 12 | $18,883 | $1,574 |
| Intelence | 12 | $16,667 | $1,389 |
| Doxycycline Hyclate | 148 | $10,269 | $69 |
| Methenamine Hippurate | 80 | $8,641 | $108 |
| Ethambutol | 60 | $4,639 | $77 |
| Ceftriaxone | 19 | $4,041 | $213 |
| Symbicort | 11 | $4,011 | $365 |
| Dicloxacillin | 26 | $3,205 | $123 |
| Azithromycin | 63 | $3,088 | $49 |
| Nitrofurantoin Mono-Macro | 14 | $1,832 | $131 |
| Cephalexin | 59 | $1,721 | $29 |
| Xopenex Hfa | 23 | $1,597 | $69 |
| Ritonavir | 12 | $1,405 | $117 |
| Clindamycin | 46 | $1,398 | $30 |
| Cefazolin | 21 | $1,273 | $61 |
| Rifampin | 31 | $1,253 | $40 |
| Valacyclovir | 11 | $1,077 | $98 |
| Amoxicillin-Clavulanate Potass | 36 | $985 | $27 |
| Hydrocodone-Acetaminophen | 32 | $870 | $27 |
| Ampicillin Trihydrate | 15 | $846 | $56 |
| Ciprofloxacin | 18 | $731 | $41 |
| Rosuvastatin | 14 | $417 | $30 |
| Dicyclomine | 11 | $385 | $35 |
| Sulfamethoxazole-Trimethoprim | 43 | $340 | $8 |
| Levofloxacin | 14 | $329 | $23 |
| Penicillin V | 11 | $298 | $27 |
| Fluticasone Propionate | 17 | $270 | $16 |
| Amoxicillin | 19 | $247 | $13 |
| Trazodone | 19 | $185 | $10 |
| Mirtazapine | 15 | $134 | $9 |
| Atorvastatin | 13 | $130 | $10 |
| Mupirocin | 14 | $127 | $9 |
| Easy Touch Alcohol Prep Pads | 12 | $109 | $9 |
| Pravastatin | 12 | $107 | $9 |
| Lisinopril | 12 | $50 | $4 |
| Benazepril | 12 | $41 | $3 |
| Losartan | 12 | $34 | $3 |
2018: 38 drugs
| Serostim | 20 | $209,062 | $10,453 |
| Odefsey | 33 | $90,419 | $2,740 |
| Voriconazole | 39 | $56,645 | $1,452 |
| Stribild | 18 | $56,374 | $3,132 |
| Genvoya | 17 | $50,684 | $2,981 |
| Vancomycin | 39 | $25,498 | $654 |
| Truvada | 13 | $23,011 | $1,770 |
| Prezista | 12 | $19,416 | $1,618 |
| Isentress | 12 | $18,426 | $1,536 |
| Intelence | 12 | $15,592 | $1,299 |
| Fluconazole | 99 | $13,589 | $137 |
| Efavirenz | 11 | $9,011 | $819 |
| Doxycycline Hyclate | 116 | $8,359 | $72 |
| Ampicillin-Sulbactam | 35 | $5,909 | $169 |
| Cefepime | 24 | $4,148 | $173 |
| Ethambutol | 31 | $2,565 | $83 |
| Clindamycin | 72 | $2,232 | $31 |
| Azithromycin | 40 | $1,800 | $45 |
| Amoxicillin-Clavulanate Potass | 50 | $1,793 | $36 |
| Ceftriaxone | 15 | $1,791 | $119 |
| Rifampin | 25 | $1,538 | $62 |
| Xopenex Hfa | 22 | $1,533 | $70 |
| Cephalexin | 45 | $1,513 | $34 |
| Nitrofurantoin Mono-Macro | 15 | $1,391 | $93 |
| Cefazolin | 12 | $1,261 | $105 |
| Levofloxacin | 22 | $1,206 | $55 |
| Ciprofloxacin | 32 | $736 | $23 |
| Hydrocodone-Acetaminophen | 28 | $664 | $24 |
| Ampicillin Trihydrate | 14 | $623 | $44 |
| Amoxicillin | 19 | $240 | $13 |
| Sulfamethoxazole-Trimethoprim | 23 | $196 | $9 |
| Diphenoxylate-Atropine | 15 | $178 | $12 |
| Pravastatin | 13 | $133 | $10 |
| Easy Touch Alcohol Prep Pads | 22 | $122 | $6 |
| Trazodone | 19 | $101 | $5 |
| Mirtazapine | 13 | $69 | $5 |
| Benazepril | 13 | $45 | $3 |
| Losartan | 12 | $34 | $3 |
2017: 37 drugs
| Serostim | 23 | $208,040 | $9,045 |
| Odefsey | 30 | $77,311 | $2,577 |
| Stribild | 16 | $48,752 | $3,047 |
| Prezista | 28 | $41,604 | $1,486 |
| Teflaro | 15 | $35,009 | $2,334 |
| Isentress | 23 | $32,498 | $1,413 |
| Voriconazole | 16 | $28,262 | $1,766 |
| Intelence | 21 | $27,434 | $1,306 |
| Truvada | 17 | $26,869 | $1,581 |
| Doxycycline Hyclate | 120 | $13,259 | $110 |
| Sustiva | 13 | $13,016 | $1,001 |
| Fluconazole | 91 | $11,455 | $126 |
| Norvir | 22 | $11,260 | $512 |
| Vancomycin | 40 | $8,848 | $221 |
| Cefepime | 27 | $6,254 | $232 |
| Amoxicillin-Clavulanate Potass | 55 | $1,720 | $31 |
| Ethambutol | 21 | $1,676 | $80 |
| Ceftriaxone | 31 | $1,613 | $52 |
| Xopenex Hfa | 20 | $1,400 | $70 |
| Rifampin | 23 | $1,313 | $57 |
| Cephalexin | 46 | $1,198 | $26 |
| Clindamycin | 51 | $1,149 | $23 |
| Dicloxacillin | 14 | $1,121 | $80 |
| Proair Hfa | 18 | $1,049 | $58 |
| Azithromycin | 26 | $1,037 | $40 |
| Hydrocodone-Acetaminophen | 18 | $614 | $34 |
| Ciprofloxacin | 27 | $396 | $15 |
| Ampicillin Trihydrate | 26 | $321 | $12 |
| Sulfamethoxazole-Trimethoprim | 16 | $190 | $12 |
| Easy Touch Alcohol Prep Pads | 39 | $188 | $5 |
| Tramadol | 17 | $104 | $6 |
| Dicyclomine | 11 | $89 | $8 |
| Benazepril | 14 | $77 | $5 |
| Trazodone | 12 | $60 | $5 |
| Mirtazapine | 11 | $49 | $4 |
| Lisinopril | 13 | $46 | $4 |
| Losartan | 12 | $35 | $3 |
2016: 30 drugs
| Stribild | 18 | $57,181 | $3,177 |
| Cubicin | 13 | $43,143 | $3,319 |
| Zerbaxa | 12 | $37,966 | $3,164 |
| Prezista | 20 | $37,410 | $1,871 |
| Vancomycin | 56 | $29,496 | $527 |
| Truvada | 18 | $26,898 | $1,494 |
| Intelence | 18 | $21,949 | $1,219 |
| Doxycycline Hyclate | 127 | $20,451 | $161 |
| Fluconazole | 85 | $18,818 | $221 |
| Sustiva | 13 | $12,215 | $940 |
| Norvir | 18 | $11,556 | $642 |
| Nafcillin | 13 | $11,114 | $855 |
| Ceftriaxone | 24 | $3,849 | $160 |
| Azithromycin | 19 | $2,836 | $149 |
| Cefepime | 14 | $2,066 | $148 |
| Cephalexin | 49 | $1,199 | $24 |
| Amoxicillin-Clavulanate Potass | 43 | $1,197 | $28 |
| Clindamycin | 35 | $1,011 | $29 |
| Rifampin | 13 | $684 | $53 |
| Cefazolin | 11 | $599 | $54 |
| Hydrocodone-Acetaminophen | 18 | $480 | $27 |
| Ampicillin Trihydrate | 20 | $397 | $20 |
| Ciprofloxacin | 33 | $367 | $11 |
| Sulfamethoxazole-Trimethoprim | 19 | $277 | $15 |
| Omeprazole | 15 | $142 | $9 |
| Easy Touch Alcohol Prep Pads | 20 | $116 | $6 |
| Tramadol | 15 | $113 | $8 |
| Terbinafine | 14 | $103 | $7 |
| Dicyclomine | 25 | $103 | $4 |
| Trazodone | 15 | $65 | $4 |
2015: 24 drugs
| Truvada | 14 | $24,555 | $1,754 |
| Doxycycline Hyclate | 105 | $22,406 | $213 |
| Fluconazole | 69 | $16,256 | $236 |
| Nafcillin | 17 | $13,628 | $802 |
| Vancomycin | 53 | $10,409 | $196 |
| Sustiva | 12 | $10,351 | $863 |
| Ceftriaxone | 26 | $5,896 | $227 |
| Ampicillin-Sulbactam | 26 | $4,481 | $172 |
| Amoxicillin-Clavulanate Potass | 49 | $1,267 | $26 |
| Clindamycin | 64 | $1,264 | $20 |
| Rifampin | 14 | $819 | $58 |
| Dicloxacillin | 13 | $760 | $58 |
| Azithromycin | 11 | $580 | $53 |
| Cephalexin | 23 | $477 | $21 |
| Hydrocodone-Acetaminophen | 14 | $318 | $23 |
| Metronidazole | 11 | $294 | $27 |
| Sulfamethoxazole-Trimethoprim | 36 | $239 | $7 |
| Ampicillin Trihydrate | 21 | $236 | $11 |
| Ciprofloxacin | 17 | $180 | $11 |
| Omeprazole | 12 | $172 | $14 |
| Pravastatin | 12 | $169 | $14 |
| Tramadol | 15 | $106 | $7 |
| Dicyclomine | 14 | $82 | $6 |
| Easy Touch Alcohol Prep Pads | 19 | $79 | $4 |
2014: 30 drugs
| Truvada | 20 | $28,510 | $1,425 |
| Voriconazole | 12 | $26,599 | $2,217 |
| Nafcillin | 20 | $18,259 | $913 |
| Fluconazole | 46 | $13,350 | $290 |
| Vancomycin | 28 | $12,524 | $447 |
| Doxycycline Hyclate | 54 | $11,821 | $219 |
| Sustiva | 12 | $9,003 | $750 |
| Piperacillin-Tazobactam | 13 | $4,315 | $332 |
| Ethambutol | 37 | $3,026 | $82 |
| Cefepime | 11 | $2,903 | $264 |
| Azithromycin | 47 | $2,345 | $50 |
| Rifampin | 42 | $2,271 | $54 |
| Nitrofurantoin Mono-Macro | 15 | $1,848 | $123 |
| Clindamycin | 69 | $1,772 | $26 |
| Amox Tr-Potassium Clavulanate | 39 | $1,119 | $29 |
| Dicloxacillin | 20 | $902 | $45 |
| Hydrocodone-Acetaminophen | 30 | $546 | $18 |
| Cephalexin | 30 | $453 | $15 |
| Nystatin | 15 | $436 | $29 |
| Ciprofloxacin | 38 | $415 | $11 |
| Oxybutynin Chloride Er | 12 | $395 | $33 |
| Ampicillin Trihydrate | 13 | $250 | $19 |
| Pravastatin | 12 | $233 | $19 |
| Sulfamethoxazole-Trimethoprim | 25 | $224 | $9 |
| Metronidazole | 11 | $223 | $20 |
| Easy Touch Alcohol Prep Pads | 29 | $220 | $8 |
| Mupirocin | 11 | $121 | $11 |
| Omeprazole | 17 | $94 | $6 |
| Tramadol | 17 | $78 | $5 |
| Prochlorperazine Maleate | 11 | $74 | $7 |
2013: 28 drugs
| Voriconazole | 16 | $40,709 | $2,544 |
| Truvada | 27 | $33,854 | $1,254 |
| Vancomycin | 19 | $10,307 | $542 |
| Sustiva | 13 | $10,012 | $770 |
| Viramune Xr | 12 | $7,163 | $597 |
| Fluconazole | 29 | $6,664 | $230 |
| Doxycycline Hyclate | 47 | $6,595 | $140 |
| Advair Diskus | 13 | $3,504 | $270 |
| Ampicillin-Sulbactam | 12 | $2,747 | $229 |
| Lovaza | 12 | $2,475 | $206 |
| Clindamycin | 58 | $1,679 | $29 |
| Amox Tr-Potassium Clavulanate | 34 | $1,668 | $49 |
| Rifampin | 19 | $1,612 | $85 |
| Ethambutol | 13 | $1,501 | $115 |
| Hydrocodone-Acetaminophen | 52 | $845 | $16 |
| Valacyclovir | 12 | $843 | $70 |
| Nystatin | 20 | $826 | $41 |
| Azithromycin | 12 | $470 | $39 |
| Oxybutynin Chloride Er | 13 | $453 | $35 |
| Pravastatin | 24 | $427 | $18 |
| Morphine Sulfate Er | 11 | $313 | $28 |
| Synthroid | 12 | $282 | $24 |
| Omeprazole | 23 | $281 | $12 |
| Sulfamethoxazole-Trimethoprim | 17 | $174 | $10 |
| Gabapentin | 12 | $109 | $9 |
| Easy Touch Alcohol Prep Pads | 11 | $86 | $8 |
| Tramadol | 14 | $76 | $5 |
| Propranolol | 12 | $61 | $5 |
Money from drug and device companies
$1,910 in 2025
| 2025 | 14 | 86 | None | $1,910 |
| 2024 | 13 | 107 | None | $2,077 |
| 2023 | 11 | 90 | None | $1,840 |
| 2022 | 15 | 109 | None | $1,789 |
| 2021 | 14 | 76 | None | $1,268 |
| 2020 | 8 | 65 | None | $1,025 |
| 2019 | 11 | 43 | None | $769 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ViiV Healthcare | Apretude | $518 | 23 payments
|
| Gilead Sciences | Biktarvy | $321 | 15 payments
|
| Astellas Pharma US | Cresemba | $302 | 8 payments
|
| Electromed | Smartvest | $208 | 19 payments
|
| Insmed | Arikayce | $143 | 5 payments
|
| EMD Serono | None | $99 | 3 payments
|
See all 86 published payments
| Baxter Healthcare | Meals · 2025-12-17 | Hillrom - Vest System Model 105 Home Care | $18 |
| Electromed | Meals · 2025-12-17 | Smartvest | $10 |
| Electromed | Meals · 2025-12-12 | Smartvest | $12 |
| ViiV Healthcare | Meals · 2025-12-09 | Apretude | $27 |
| Astellas Pharma US | Education · 2025-12-05 | None | $90 |
| Electromed | Meals · 2025-12-04 | Smartvest | $11 |
| Gilead Sciences | Meals · 2025-12-04 | Biktarvy | $21 |
| EMD Serono | Meals · 2025-12-04 | None | $35 |
| Insmed | Meals · 2025-12-02 | Arikayce | $14 |
| Electromed | Meals · 2025-11-26 | Smartvest | $14 |
| Insmed | Meals · 2025-11-19 | Arikayce | $32 |
| Gilead Sciences | Meals · 2025-11-18 | Biktarvy | $28 |
| ViiV Healthcare | Meals · 2025-11-16 | Dovato | $34 |
| Electromed | Meals · 2025-11-14 | Smartvest | $10 |
| Electromed | Meals · 2025-11-12 | Smartvest | $13 |
| Astellas Pharma US | Meals · 2025-11-12 | Cresemba | $24 |
| Astellas Pharma US | Education · 2025-11-12 | None | $40 |
| Gilead Sciences | Meals · 2025-11-11 | None | $8 |
| Electromed | Meals · 2025-11-07 | Smartvest | $10 |
| ViiV Healthcare | Meals · 2025-11-04 | Apretude | $20 |
| Theratechnologies | Meals · 2025-10-18 | Egrifta | $27 |
| Insmed | Meals · 2025-10-15 | Arikayce | $32 |
| ViiV Healthcare | Meals · 2025-10-10 | Cabenuva | $15 |
| Gilead Sciences | Meals · 2025-10-08 | None | $23 |
| ViiV Healthcare | Meals · 2025-10-01 | Dovato | $16 |
| Gilead Sciences | Meals · 2025-10-01 | None | $18 |
| Astellas Pharma US | Meals · 2025-09-19 | Cresemba | $18 |
| Paratek Pharmaceuticals | Meals · 2025-09-18 | Nuzyra | $23 |
| ViiV Healthcare | Meals · 2025-09-16 | Apretude | $26 |
| ViiV Healthcare | Meals · 2025-09-15 | Cabenuva | $31 |
| Gilead Sciences | Meals · 2025-09-11 | None | $7 |
| Electromed | Meals · 2025-08-29 | Smartvest | $11 |
| Electromed | Meals · 2025-08-22 | Smartvest | $9 |
| Gilead Sciences | Meals · 2025-08-22 | None | $17 |
| ViiV Healthcare | Meals · 2025-08-15 | Cabenuva | $9 |
| EMD Serono | Meals · 2025-08-15 | None | $24 |
| Electromed | Meals · 2025-08-14 | Smartvest | $9 |
| Electromed | Meals · 2025-08-08 | Smartvest | $19 |
| ViiV Healthcare | Meals · 2025-08-04 | Dovato | $31 |
| Gilead Sciences | Meals · 2025-07-25 | None | $29 |
| Astellas Pharma US | Education · 2025-07-23 | None | $45 |
| Astellas Pharma US | Meals · 2025-07-15 | Cresemba | $31 |
| ViiV Healthcare | Meals · 2025-07-14 | Dovato | $21 |
| Electromed | Meals · 2025-07-11 | Smartvest | $10 |
| ViiV Healthcare | Meals · 2025-07-10 | Apretude | $23 |
| Merck Sharp & Dohme | Meals · 2025-07-08 | None | $28 |
| Paratek Pharmaceuticals | Meals · 2025-07-03 | Nuzyra | $14 |
| Gilead Sciences | Meals · 2025-06-24 | None | $21 |
| ViiV Healthcare | Meals · 2025-06-17 | Cabenuva | $7 |
| Electromed | Meals · 2025-06-17 | Smartvest | $15 |
| Gilead Sciences | Meals · 2025-06-17 | None | $30 |
| ViiV Healthcare | Meals · 2025-06-12 | Cabenuva | $13 |
| ViiV Healthcare | Meals · 2025-06-10 | Apretude | $18 |
| Electromed | Meals · 2025-06-05 | Smartvest | $9 |
| ViiV Healthcare | Meals · 2025-05-26 | Dovato | $33 |
| Gilead Sciences | Meals · 2025-05-23 | None | $25 |
| La Jolla Pharmaceutical | Meals · 2025-05-15 | Xacduro | $25 |
| Aimmune Therapeutics | Meals · 2025-05-15 | Vowst | $20 |
| Philips North America | Meals · 2025-05-13 | Vest Therapy Und | $23 |
| ViiV Healthcare | Meals · 2025-05-12 | Apretude | $24 |
| Gilead Sciences | Meals · 2025-05-08 | None | $20 |
| Theratechnologies | Meals · 2025-04-17 | Egrifta | $30 |
| Electromed | Meals · 2025-04-10 | Smartvest | $5 |
| Electromed | Meals · 2025-04-10 | Smartvest | $9 |
| EMD Serono | Meals · 2025-04-10 | None | $41 |
| Insmed | Meals · 2025-04-01 | Arikayce | $34 |
| ViiV Healthcare | Meals · 2025-04-01 | Apretude | $32 |
| Gilead Sciences | Meals · 2025-03-20 | Veklury | $23 |
| Gilead Sciences | Meals · 2025-03-19 | None | $21 |
| La Jolla Pharmaceutical | Meals · 2025-03-11 | Xacduro | $29 |
| ViiV Healthcare | Meals · 2025-03-06 | Dovato | $30 |
| Qiagen | Meals · 2025-03-06 | None | $29 |
| Philips North America | Meals · 2025-03-04 | Vest Therapy Und | $28 |
| Astellas Pharma US | Meals · 2025-02-25 | Cresemba | $20 |
| Paratek Pharmaceuticals | Meals · 2025-02-12 | Nuzyra | $24 |
| Electromed | Meals · 2025-02-11 | Smartvest | $12 |
| Gilead Sciences | Meals · 2025-02-07 | None | $30 |
| ViiV Healthcare | Meals · 2025-02-04 | Apretude | $30 |
| ViiV Healthcare | Meals · 2025-01-29 | Dovato | $29 |
| ViiV Healthcare | Meals · 2025-01-24 | Apretude | $20 |
| Insmed | Meals · 2025-01-23 | Arikayce | $31 |
| ViiV Healthcare | Meals · 2025-01-21 | Cabenuva | $18 |
| Electromed | Meals · 2025-01-21 | Smartvest | $10 |
| Electromed | Meals · 2025-01-16 | Smartvest | $12 |
| Astellas Pharma US | Meals · 2025-01-16 | Cresemba | $35 |
| ViiV Healthcare | Meals · 2025-01-09 | Cabenuva | $11 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,077
| ViiV Healthcare | Apretude | $807 | 43 payments
|
| Gilead Sciences | None | $271 | 11 payments
|
| Electromed | Smartvest | $223 | 23 payments
|
| Insmed | Arikayce | $175 | 9 payments
|
| Paratek Pharmaceuticals | Nuzyra | $170 | 3 payments
|
| Astellas Pharma US | Cresemba | $137 | 6 payments
|
| EMD Serono | Serostim | $87 | 3 payments
|
| Merck Sharp & Dohme | Dificid | $58 | 3 payments
|
| Baxter Healthcare | Hillrom - Monarch Airway Clearance System | $53 | 2 payments
|
| Abbvie | Mavyret | $30 | 1 payment
|
| Theratechnologies | Egrifta | $25 | 1 payment
|
| Aimmune Therapeutics | Vowst | $23 | 1 payment
|
| Philips North America | (8874) Incourage | $16 | 1 payment
|
2023: $1,840
| ViiV Healthcare | Dovato | $527 | 32 payments
|
| Gilead Sciences | None | $308 | 13 payments
|
| Astellas Pharma US | Cresemba | $296 | 7 payments
|
| Theratechnologies | Egrifta | $157 | 7 payments
|
| Merck Sharp & Dohme | Dificid | $129 | 7 payments
|
| Electromed | Smartvest | $110 | 11 payments
|
| EMD Serono | Serostim | $109 | 4 payments
|
| Insmed | Arikayce | $73 | 3 payments
|
| Philips Electronics North America | (8874) Incourage | $59 | 2 payments
|
| Ferring Pharmaceuticals | Rebyota | $51 | 3 payments
|
| Janssen Scientific Affairs | Prezista | $21 | 1 payment
|
2022: $1,789
| ViiV Healthcare | Cabenuva | $437 | 34 payments
|
| Insmed | Arikayce | $225 | 13 payments
|
| Gilead Sciences | None | $224 | 11 payments
|
| Janssen Biotech | Symtuza | $186 | 8 payments
|
| Abbvie | Avycaz | $162 | 11 payments
|
| Merck Sharp & Dohme | Dificid | $125 | 8 payments
|
| EMD Serono | None | $122 | 9 payments
|
| Theratechnologies | Egrifta | $93 | 4 payments
|
| Mayne Pharma | None | $59 | 3 payments
|
| Paratek Pharmaceuticals | Nuzyra | $37 | 2 payments
|
| Electromed | Smartvest | $36 | 2 payments
|
| Janssen Scientific Affairs | Symtuza | $27 | 1 payment
|
| La Jolla Pharmaceutical | Giapreza | $23 | 1 payment
|
| Ferring Pharmaceuticals | None | $18 | 1 payment
|
| Philips Electronics North America | (7999) Src Und | $16 | 1 payment
|
2021: $1,268
| Insmed | Arikayce | $290 | 31 payments
|
| EMD Serono | None | $152 | 7 payments
|
| La Jolla Pharmaceutical | Xerava | $141 | 5 payments
|
| Mayne Pharma | None | $95 | 5 payments
|
| Janssen Biotech | Symtuza | $92 | 4 payments
|
| ViiV Healthcare | Cabenuva | $83 | 4 payments
|
| Janssen Scientific Affairs | Symtuza | $79 | 3 payments
|
| Gilead Sciences | None | $70 | 4 payments
|
| Merck Sharp & Dohme | Pifeltro | $69 | 3 payments
|
| AbbVie | Avycaz | $65 | 4 payments
|
| Paratek Pharmaceuticals | Nuzyra | $54 | 2 payments
|
| Theratechnologies | Trogarzo | $49 | 2 payments
|
| Astellas Pharma US | Cresemba | $16 | 1 payment
|
| Philips Electronics North America | (8874) Incourage | $13 | 1 payment
|
2020: $1,025
| EMD Serono | Serostim | $192 | 8 payments
|
| Merck Sharp & Dohme | Zerbaxa | $188 | 12 payments
|
| Insmed | Arikayce | $186 | 21 payments
|
| Gilead Sciences | None | $159 | 10 payments
|
| Janssen Biotech | Symtuza | $147 | 6 payments
|
| ViiV Healthcare | Dovato | $80 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $42 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $31 | 2 payments
|
2019: $769
| Merck Sharp & Dohme | Zerbaxa | $168 | 11 payments
|
| Gilead Sciences | None | $141 | 9 payments
|
| EMD Serono | Serostim | $111 | 8 payments
|
| Janssen Biotech | Symtuza | $91 | 5 payments
|
| Janssen Products LP | Prezcobix | $90 | 2 payments
|
| Theratechnologies | Egrifta | $65 | 3 payments
|
| Melinta Therapeutics | Baxdela | $24 | 1 payment
|
| ViiV Healthcare | Dovato | $23 | 1 payment
|
| Tetraphase Pharmaceuticals | Xerava | $23 | 1 payment
|
| Insmed | Arikayce | $17 | 1 payment
|
| Philips Electronics North America | Trilogy 100 | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 19.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154380343
- Licence
- CA A88072California A88072: Current · expires 2028-05-31
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 7035 N Maple Ave, Suit-101, Fresno, CA, 93720
- NPI first listed
- 2006-03-17
- NPI last updated
- 2012-09-26
This is when the NPI record was last certified, not a medical board exam.